Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia
Jhih-Pu Syu, Jen‐Tsan Chi, Hsiu‐Ni Kung
Oncotarget (2016) Vol. 7, Iss. 12, pp. 14659-14672
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Xinming Jing, Fengming Yang, Chuchu Shao, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 1567
Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui, Jing‐Quan Wang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2018) Vol. 41, pp. 1-25
Closed Access | Times Cited: 560
Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling
Ming Luo, Shang Li, Michael Brooks, et al.
Cell Metabolism (2018) Vol. 28, Iss. 1, pp. 69-86.e6
Open Access | Times Cited: 326
The Role of Nrf2 Activity in Cancer Development and Progression
Alina‐Andreea Zimța, Diana Cenariu, Alexandru Irimie, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1755-1755
Open Access | Times Cited: 228
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Luciana Mosca, Andrea Ilari, Francesco Fazi, et al.
Drug Resistance Updates (2021) Vol. 54, pp. 100742-100742
Closed Access | Times Cited: 228
Inhibition of cancer antioxidant defense by natural compounds
Alicja Sznarkowska, Anna Kostecka, Katarzyna Meller, et al.
Oncotarget (2016) Vol. 8, Iss. 9, pp. 15996-16016
Open Access | Times Cited: 203
Bioactive Compounds in Oxidative Stress-Mediated Diseases: Targeting the NRF2/ARE Signaling Pathway and Epigenetic Regulation
Muthu Thiruvengadam, Baskar Venkidasamy, Umadevi Subramanian, et al.
Antioxidants (2021) Vol. 10, Iss. 12, pp. 1859-1859
Open Access | Times Cited: 155
Endoplasmic Reticulum Stress and Unfolded Protein Response in Breast Cancer: The Balance between Apoptosis and Autophagy and Its Role in Drug Resistance
Lorenza Sisinni, Michele Pietrafesa, Silvia Lepore, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 857-857
Open Access | Times Cited: 151
Targeting ferroptosis in breast cancer
Zhaoqing Li, Lini Chen, Cong Chen, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 144
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 119
Role of Oxidative Stress in the Occurrence, Development, and Treatment of Breast Cancer
Rui Dong, Jing Wang, Rijian Guan, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 104-104
Open Access | Times Cited: 3
Controversy about pharmacological modulation of Nrf2 for cancer therapy
Lidija Milković, Neven Žarković, Luciano Saso
Redox Biology (2017) Vol. 12, pp. 727-732
Open Access | Times Cited: 130
Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia
Rachel K. Toth, Noel A. Warfel
Antioxidants (2017) Vol. 6, Iss. 2, pp. 27-27
Open Access | Times Cited: 115
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
David P. Hill, Akeena Harper, Joan Malcolm, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 105
Lithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer
Patrik Kovács, Tamás Csonka, Tündé Kovàcs, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1255-1255
Open Access | Times Cited: 96
Regulation of Gene Expression under Hypoxic Conditions
Koh Nakayama, Naoyuki Kataoka
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3278-3278
Open Access | Times Cited: 93
Glycosylation of KEAP1 links nutrient sensing to redox stress signaling
Po‐Han Chen, Timothy J. Smith, Jianli Wu, et al.
The EMBO Journal (2017) Vol. 36, Iss. 15, pp. 2233-2250
Open Access | Times Cited: 92
Myeloid‐derived suppressor cells as effectors of immune suppression in cancer
Athalia R. Pyzer, Leandra Cole, Jacalyn Rosenblatt, et al.
International Journal of Cancer (2016) Vol. 139, Iss. 9, pp. 1915-1926
Open Access | Times Cited: 91
High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP1 upregulation
Izadora de Souza, Linda Karolynne Seregni Monteiro, Camila Banca Guedes, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 50
Dynamic Magneto-Softening of 3D Hydrogel Reverses Malignant Transformation of Cancer Cells and Enhances Drug Efficacy
Yufeng Shou, Xin Yong Teo, Xianlei Li, et al.
ACS Nano (2023) Vol. 17, Iss. 3, pp. 2851-2867
Closed Access | Times Cited: 31
Elemene induces cell apoptosis via inhibiting glutathione synthesis in lung adenocarcinoma
Gao-Qian Song, Pu Wu, Xue-Man Dong, et al.
Journal of Ethnopharmacology (2023) Vol. 311, pp. 116409-116409
Closed Access | Times Cited: 30
The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer
Hadi Fakheri, Mir Amirhossein Sajadi, Ahmad Afrashteh, et al.
Biochemia Medica (2023) Vol. 33, Iss. 3, pp. 266-278
Open Access | Times Cited: 23
Decoding contextual crosstalk: revealing distinct interactions between non-coding RNAs and unfolded protein response in breast cancer
Negin Karamali, Arshia Daraei, Arman Rostamlou, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Influence of Matrigel on Single- and Multiple-Spheroid Cultures in Breast Cancer Research
Mădălina Andreea Badea, Mihaela Balaș, Anca Hermenean, et al.
SLAS DISCOVERY (2019) Vol. 24, Iss. 5, pp. 563-578
Open Access | Times Cited: 73
Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer
Marco Fiorillo, Federica Sotgia, Diego Sisci, et al.
Oncotarget (2017) Vol. 8, Iss. 12, pp. 20309-20327
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top